-
Day Three at
#HPAPI Summit 2019 - Discussing Enhanced Conceptual Design Framework and celebrating client success!@ALUMA1_@smarthepapic.twitter.com/uDyYOi8ML4
-
#HPAPI (High Potency Active Pharmaceutical Ingredients) Market Trends Analysis To 2025 Read: http://bit.ly/33hBSOn@LonzaGroup@Novartis@BASFAgProducts@CARBOGEN_AMCIS@LillyPad@TevaUSA@pfizer@Roche@boehringerus@Merck@BayerPharma@sanofi@SigmaAldrichpic.twitter.com/KUnR2Q70bR
-
The
#HPAPI market is set to reach $26billion in 2023 - do CDMOs need to prepare for an increase in demand in the future? Read more: https://bit.ly/2GDFWzU via@OutsourcPharma -
The HPAPI Summit in Boston, USA is only 2 weeks away. Our US team will be in attendance ready to discuss our solutions for HPAPI & API containment.
#HPAPI#pharmaceutical#containmentpic.twitter.com/ziopEDIQCb
-
In 3 weeks our US team will be at the 8th annual HPAPI Summit in Boston, MA. They'll be available to discuss our solutions for handling Highly Potent APIs.
#HPAPI#pharmaceutical#containmentpic.twitter.com/LkMSONa2dA
-
#HPAPI Capacity Challenges - do we have sufficient equipment, facilities and infrastructure to handle it? -
Andrew Kyle R&D Chemist at our
#SwordsCampus presenting on our#HighPotency#API capabilities during the#HPAPI Summit in#Boston yesterday.#sk#skfamily#skbiotek#ampac#ampacfc#ampacfinechemicals#pharmaceuticalmanufacturing#pharmaindustry#cdmo…https://lnkd.in/gtTfxRE -
Three weeks until
@MartynR_Solo is at the HPAPI Summit in Boston! Come hear him talk about ADC compounding in a single-use flexible isolator with excellent containment performance#adccompounding#HPAPI#HPAPISummitpic.twitter.com/Gnghk7UL3O
-
With only 3 weeks left until the 2019
#HPAPI USA conference, the attendee list has just been released. You can view it in the Download Center https://bit.ly/2ogP2fe pic.twitter.com/dbwGUWMG2Z
-
We are delighted to announce the opening of new state-of-the-art
#HPAPI Process Development &#GMP Manufacturing Kilo-Labs at Riverview, MI site. This expansion will enable us to support our global customers in gearing up for future demands. Contact us: https://lnkd.in/f7XGM9Z pic.twitter.com/32b5ZZ0yI2
-
This week the 2020
#HPAPI conference brochure was released - Register before Friday 13th December and save £500 https://bit.ly/2Peo4jI pic.twitter.com/cjDZwib972
-
Discussing developments on Highly Potent APIs with industry expert, Richard Arnett for the HPAPI USA conference 2019 - view the interview https://bit.ly/2mqpdsn
#HPAPI pic.twitter.com/1LcxclzXIu
-
MINAKEM will be exhibiting at CPhI Worldwide in Frankfort, Meet us at our stand # 101B30, November 5-7, 2019. Prepare your visit and schedule a meeting with our team now.
#API#HPAPI#activepharmaceuticalingredients#CDMP#CMO#CPHI#Pennakem#Minascentpic.twitter.com/lpMGalucv7
-
The need for a blueprint emergency plan to avoid a
#HPAPI crisis@WorldPharmaNews |#ECM http://bit.ly/2ILn82L -
Developing Containment, Formulation and Manufacturing Strategies for maximum HPAPI Success - only 3 weeks left until SMi's
#HPAPI USA Conference taking place in Boston this October https://bit.ly/2YvDxSs pic.twitter.com/IMjAy1OzDr
-
Industry Dynamics News:
#Advancements in#HPAPI#Manufacturing#Technologies Read More Detailed Article@ http://bit.ly/2pgOCmD |#HighPotency#API#industry#pharmacy#Pharmaceutical#research#journorequest#PRrequest#BloggerRequest -
How is
#Lonza helping address#HPAPI manufacturing and containment challenges? Join us at the Highly Potent APIs Summit 2020 on 19-21 February in Prague, CZ, to learn more#nexttogether#API#ADC@Qepler https://pharma.lonza.com/events/hpapi-summit-prague …pic.twitter.com/DA8rKUkk3S
-
#Active#pharmaceutical ingredients that require special#handling due to#toxicity and use extremely small doses in finished#drugs. Join us & Learn more at#HPAPI#conference on 2 - 3 March 2020 at Mumbai. Register Now: http://hpapi.biotrains.com/ pic.twitter.com/mHSfFGpmkF
-
Occupational Banding Systems - William Hawkins from GSK discusses Toxicology of new compounds with novel mechanism of action at
#HPAPI 2020 - https://bit.ly/2GBzCIy pic.twitter.com/TWQ9Q9Iwn0
-
Novartis provide a keynote address at
#HPAPI 2020 where Andreas Schreiner, Head of Validation focuses on "Manufacture of highly active drug products in shared facilities" https://bit.ly/2u09yUO#HighlyPotentpic.twitter.com/21q8Y1fEP4
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.